Optison

Thank you for your interest in Optison. This area of our website is currently in the process of being updated. Please check back soon.

Product Indication

Optison™(Perflutren Protein-Type A Microspheres Injectable Suspension, USP)

OPTISON is indicated for use in patients with suboptimal echocardiograms and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of OPTISON with exercise stress or pharmacologic stress testing has not been established.

Please see the Dear Healthcare Provider Letter and full Prescribing Information for the OPTISON product.

WARNING: Serious Cardiopulmonary Reactions

Serious cardiopulmonary reactions, including fatalities, have occurred during or following perflutrencontaining microsphere administration.

  • Assess all patients for the presence of any condition that precludes OPTISON administration (see CONTRAINDICATIONS).
  • In patients with pulmonary hypertension or unstable cardiopulmonary conditions, monitor vital sign measurements, electrocardiography, and cutaneous oxygen saturation during and for at least 30 minutes after OPTISON administration (see WARNINGS).
  • Always have resuscitation equipment and trained personnel readily available.

 

Customer Service

Customer service can be reached Toll-free Monday - Friday
8:30 am to 5:00 pm ET
 

Customer Service: 1 800 292 8514
Reimbursement Hotline: 1 800 767 6664
Medical Professional Services: 1 800 654 0118